Abacus Finance Group, a provider of cash flow-based, classic senior debt for sponsor-led buyouts of lower middle-market companies, served as senior secured credit facilities administrative agent and sole lender for senior secured credit facilities to support the leveraged buyout of Sabai Group by Thompson Street Capital Partners. Additionally, Abacus made an equity co-investment in Sabai Group.
Founded in 2017 and headquartered in Chesterfield, MO, Sabai Group is a provider of regulatory and safety review solutions for clinical trials related to cell and gene therapy. Based in St. Louis, Thompson Street Capital Partners is a middle-market private equity firm that helps transform already-exceptional businesses into market leaders.
“As in past transactions, we were impressed by the Abacus team’s speed of execution and ease of documentation. Once again, they were responsive, flexible, easy to work with, and able to provide certainty of closure early,” Mark Chan, vice president of Thompson Street Capital Partners , said.
“Our longstanding partnership with Thompson Street Capital Partners, which shares our lower middle-market focus, has become one of our best client relationships,” Tim Clifford, president and CEO of Abacus, said. “We know that when they come to us with a transaction, it will involve a high-quality company like Sabai Group.”
“What is important to them – in addition to speed and certainty of close – is our flexibility in structuring transactions and the emphasis we place on exceptional client service – all part of our total partnership approach,” Sean McKeever, managing director and COO of Abacus, said.
Abacus team members involved in the transaction included Sean McKeever, Joseph Lee and Greg Scanlon. Legal counsel was provided to Abacus by Goulston & Storrs.
